Dapagliflozin linked to lower frailty odds in kidney disease study
Among prefrail adults over 65 with hypertension and chronic kidney disease, dapagliflozin users had lower frailty-progression odds than nonusers at one year (adjusted…Among prefrail adults over 65 with hypertension and chronic kidney disease, dapagliflozin users had lower frailty-progression odds than nonusers at one year (adjusted odds ratio 0.130).






























